Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab.
Cold agglutinin immunohaemolytic anaemia (CAIA) responds poorly to standard treatment. We report a case of marginal zone lymphoma complicated by CAIA that responded to rituximab after failing to respond to corticosteroids and chlorambucil.
Petit
José
J
Servei d'Hematologia Clinica, Institut Català d'Oncologia, Ciutat Sanitària i Universitària de Bellvitge, Spain. ppptit@ico.scs.es
Clavo
Mercedes
M
de Sevilla
Alberto Fernández
AF
González-Barca
Eva
E
Domingo-Doménech
Eva
E
Grañena
Albert
A
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000743:Anemia, Hemolytic / Q000150:complications* / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D002699:Chlorambucil; D000069283:Rituximab